ESOMEPRAZOLE

ESOMEPRAZOLE was reported 234522 times

These side effects are most commonly reported by patients taking ESOMEPRAZOLE:

# Side effect Count
0 CHRONIC KIDNEY DISEASE 5035
1 ACUTE KIDNEY INJURY 4744
2 NAUSEA 4382
3 DIARRHOEA 4163
4 HEADACHE 3797
5 FATIGUE 3794
6 DRUG INEFFECTIVE 3633
7 OFF LABEL USE 3616
8 DYSPNOEA 3492
9 PAIN 2945
10 VOMITING 2917
11 ARTHRALGIA 2765
12 PYREXIA 2671
13 MALAISE 2640
14 DIZZINESS 2294
15 FALL 2233
16 ASTHENIA 2206
17 COUGH 2067
18 DRUG INTERACTION 2045
19 PRURITUS 2028
20 PNEUMONIA 1961
21 RENAL FAILURE 1954
22 ABDOMINAL PAIN UPPER 1915
23 RASH 1877
24 ABDOMINAL PAIN 1719
25 ANXIETY 1698
26 WEIGHT DECREASED 1599
27 GASTROOESOPHAGEAL REFLUX DISEASE 1554
28 CONDITION AGGRAVATED 1545
29 HYPERTENSION 1525
30 BACK PAIN 1449
31 INSOMNIA 1415
32 ABDOMINAL DISCOMFORT 1342
33 CHEST PAIN 1336
34 PAIN IN EXTREMITY 1336
35 CONFUSIONAL STATE 1314
36 ANAEMIA 1310
37 HYPOTENSION 1280
38 DECREASED APPETITE 1278
39 DEATH 1277
40 HYPERHIDROSIS 1271
41 MUSCULAR WEAKNESS 1229
42 RENAL INJURY 1214
43 PRODUCT USE IN UNAPPROVED INDICATION 1213
44 COVID-19 1200
45 END STAGE RENAL DISEASE 1167
46 PALPITATIONS 1164
47 TACHYCARDIA 1097
48 SOMNOLENCE 1089
49 BLOOD PRESSURE INCREASED 1079
50 DEHYDRATION 1077
51 PERIPHERAL SWELLING 1058
52 DEPRESSION 1014
53 FEELING ABNORMAL 1005
54 HYPERSENSITIVITY 1005
55 MYALGIA 984
56 ARTHRITIS 956
57 HYPONATRAEMIA 944
58 TINNITUS 938
59 CONSTIPATION 917
60 DRUG INTOLERANCE 888
61 MIGRAINE 883
62 ALOPECIA 875
63 URINARY TRACT INFECTION 875
64 THROMBOCYTOPENIA 867
65 DRUG HYPERSENSITIVITY 865
66 INTENTIONAL PRODUCT USE ISSUE 862
67 RHEUMATOID ARTHRITIS 862
68 RENAL IMPAIRMENT 859
69 DYSPHAGIA 851
70 ANGIOEDEMA 840
71 ERYTHEMA 819
72 SEPSIS 814
73 ASTHMA 809
74 GENERAL PHYSICAL HEALTH DETERIORATION 808
75 WEIGHT INCREASED 799
76 NASOPHARYNGITIS 795
77 TUBULOINTERSTITIAL NEPHRITIS 795
78 SYNCOPE 792
79 HEART RATE INCREASED 778
80 HYPOKALAEMIA 776
81 CEREBROVASCULAR ACCIDENT 775
82 MYOCARDIAL INFARCTION 768
83 GASTROINTESTINAL DISORDER 765
84 NEUTROPENIA 750
85 BLOOD GLUCOSE INCREASED 747
86 JOINT SWELLING 745
87 SINUSITIS 721
88 MEMORY IMPAIRMENT 719
89 HALLUCINATION 716
90 INFECTION 716
91 VISUAL IMPAIRMENT 715
92 DIPLOPIA 710
93 OEDEMA PERIPHERAL 704
94 CHILLS 695
95 CARDIAC FAILURE 684
96 BLOOD CREATININE INCREASED 682
97 BLINDNESS 679
98 CHEST DISCOMFORT 671
99 DYSPEPSIA 670
100 TOXICITY TO VARIOUS AGENTS 668
101 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 666
102 NEPHROLITHIASIS 665
103 INFLUENZA 664
104 MUSCLE SPASMS 662
105 HYPOMAGNESAEMIA 659
106 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 659
107 PRODUCT USE ISSUE 646
108 GAIT DISTURBANCE 641
109 HAEMOGLOBIN DECREASED 624
110 INTERSTITIAL LUNG DISEASE 620
111 ATRIAL FIBRILLATION 618
112 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 616
113 PARAESTHESIA 611
114 DRY SKIN 604
115 DISTURBANCE IN ATTENTION 603
116 PULMONARY EMBOLISM 602
117 COGNITIVE DISORDER 600
118 TREMOR 598
119 METABOLIC ACIDOSIS 591
120 WHEEZING 586
121 MUSCULOSKELETAL STIFFNESS 585
122 URTICARIA 584
123 AMNESIA 581
124 VISION BLURRED 572
125 INFUSION RELATED REACTION 556
126 OXYGEN SATURATION DECREASED 553
127 NIGHTMARE 552
128 RESPIRATORY FAILURE 544
129 LOSS OF CONSCIOUSNESS 542
130 OVERDOSE 535
131 TRANSIENT ISCHAEMIC ATTACK 535
132 PRODUCT DOSE OMISSION ISSUE 534
133 CATARACT 526
134 HYPOAESTHESIA 523
135 C-REACTIVE PROTEIN INCREASED 520
136 HYPOCALCAEMIA 519
137 VENTRICULAR TACHYCARDIA 518
138 CARDIAC DISORDER 517
139 ALANINE AMINOTRANSFERASE INCREASED 514
140 NEUROPATHY PERIPHERAL 514
141 INTENTIONAL PRODUCT MISUSE 512
142 RENAL DISORDER 512
143 HAEMATURIA 503
144 SEPTIC SHOCK 503
145 ABDOMINAL DISTENSION 502
146 SWOLLEN TONGUE 500
147 BURNING SENSATION 499
148 COMA 494
149 HYPOTHYROIDISM 493
150 INTENTIONAL OVERDOSE 491
151 PSORIASIS 485
152 PERICARDITIS 483
153 VERTIGO 482
154 RHABDOMYOLYSIS 477
155 SUICIDE ATTEMPT 477
156 BRONCHITIS 476
157 LIP SWELLING 475
158 FIBROMYALGIA 474
159 HYPERKALAEMIA 470
160 OROPHARYNGEAL PAIN 468
161 INCORRECT DOSE ADMINISTERED 460
162 CHOLESTASIS 459
163 FEBRILE NEUTROPENIA 455
164 APHASIA 451
165 SLEEP APNOEA SYNDROME 443
166 CARDIAC FAILURE CONGESTIVE 442
167 MUSCLE TWITCHING 439
168 RHINORRHOEA 439
169 GASTROINTESTINAL HAEMORRHAGE 438
170 VASCULITIS 437
171 DRY MOUTH 433
172 STRESS 433
173 SEROTONIN SYNDROME 430
174 SWELLING FACE 429
175 EYE PAIN 428
176 SUBARACHNOID HAEMORRHAGE 428
177 DEEP VEIN THROMBOSIS 427
178 LACTIC ACIDOSIS 427
179 SEDATION 427
180 ANAPHYLACTIC REACTION 426
181 DYSARTHRIA 424
182 INFLAMMATION 424
183 ECZEMA 422
184 EYE PRURITUS 422
185 PANCYTOPENIA 420
186 LUNG DISORDER 419
187 ASPARTATE AMINOTRANSFERASE INCREASED 416
188 PLATELET COUNT DECREASED 416
189 HOSPITALISATION 415
190 INJECTION SITE PAIN 414
191 HAEMATEMESIS 412
192 HAEMATOCHEZIA 411
193 DYSPHONIA 410
194 CARDIO-RESPIRATORY ARREST 409
195 ATRIAL TACHYCARDIA 408
196 FACIAL PAIN 408
197 INFLUENZA LIKE ILLNESS 408
198 TENSION HEADACHE 408
199 ANOSMIA 407
200 RECTAL HAEMORRHAGE 407
201 PLEURAL EFFUSION 403
202 PAIN OF SKIN 396
203 NEPHROPATHY 395
204 CAROTID ARTERY OCCLUSION 392
205 OSTEOARTHRITIS 392
206 SWELLING 392
207 TREATMENT FAILURE 392
208 BALANCE DISORDER 390
209 CARDIOSPASM 389
210 PRURITUS GENITAL 386
211 SLEEP TERROR 384
212 PALMOPLANTAR KERATODERMA 382
213 WHITE BLOOD CELL COUNT DECREASED 380
214 MEDICATION ERROR 379
215 NASAL CONGESTION 379
216 ASCITES 377
217 ALTERED STATE OF CONSCIOUSNESS 374
218 ADVERSE DRUG REACTION 370
219 HEPATIC ENZYME INCREASED 368
220 SLEEP DISORDER 367
221 THERAPEUTIC PRODUCT EFFECT DECREASED 366
222 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 364
223 CONTRAINDICATED PRODUCT ADMINISTERED 363
224 COORDINATION ABNORMAL 361
225 BLOOD TEST ABNORMAL 357
226 CONTUSION 357
227 ELECTROCARDIOGRAM QT PROLONGED 356
228 ANGINA PECTORIS 353
229 GASTRITIS 353
230 DISEASE PROGRESSION 352
231 HEPATIC CYTOLYSIS 352
232 DRY EYE 351
233 DYSGEUSIA 351
234 HEMIPLEGIA 351
235 RASH MACULO-PAPULAR 349
236 MOBILITY DECREASED 348
237 SEIZURE 348
238 PANCREATITIS ACUTE 347
239 SKIN EXFOLIATION 347
240 BLOOD PRESSURE SYSTOLIC INCREASED 346
241 RASH PAPULAR 345
242 DYSPNOEA EXERTIONAL 340
243 PRODUCTIVE COUGH 339
244 HEMIPARESIS 333
245 UPPER RESPIRATORY TRACT INFECTION 332
246 AGRANULOCYTOSIS 330
247 LOWER RESPIRATORY TRACT INFECTION 325
248 RASH PRURITIC 324
249 CYSTITIS 322
250 EATING DISORDER 322
251 MAJOR DEPRESSION 320
252 BRADYCARDIA 317
253 CARPAL TUNNEL SYNDROME 317
254 HAEMORRHAGE 317
255 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 317
256 DYSURIA 313
257 MOTOR DYSFUNCTION 313
258 DIABETES MELLITUS 310
259 DRUG-INDUCED LIVER INJURY 310
260 CARDIAC ARREST 308
261 HYPOGLYCAEMIA 308
262 PULMONARY OEDEMA 308
263 BLOOD PRESSURE FLUCTUATION 302
264 FLUSHING 302
265 RHINITIS ALLERGIC 302
266 SKIN ULCER 302
267 PROTEINURIA 301
268 HEPATOCELLULAR INJURY 299
269 PHYSICAL DECONDITIONING 299
270 BLOOD PRESSURE DECREASED 298
271 RENAL FAILURE ACUTE 298
272 PANCREATITIS 296
273 PERSONALITY DISORDER 296
274 PRESYNCOPE 296
275 GENERALISED OEDEMA 294
276 PHOTOPHOBIA 292
277 THROAT IRRITATION 291
278 ACCIDENTAL OVERDOSE 290
279 MUSCLE SPASTICITY 290
280 SENSITISATION 290
281 COLITIS ULCERATIVE 289
282 ARTHROPATHY 286
283 LIVER DISORDER 286
284 HAEMORRHAGIC STROKE 285
285 NECK PAIN 285
286 OSTEOPOROSIS 285
287 AFFECT LABILITY 283
288 ILLNESS 283
289 DEPRESSED MOOD 282
290 EOSINOPHILIA 282
291 HOT FLUSH 282
292 SENSORY LOSS 282
293 FLATULENCE 281
294 IMPAIRED WORK ABILITY 280
295 MALIGNANT NEOPLASM PROGRESSION 280
296 MULTIPLE ORGAN DYSFUNCTION SYNDROME 279
297 POLYCYSTIC OVARIES 278
298 SYSTEMIC LUPUS ERYTHEMATOSUS 276
299 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 275
300 RESPIRATORY TRACT CONGESTION 275
301 LEUKOPENIA 272
302 RESPIRATORY DISTRESS 271
303 DISCOMFORT 270
304 MUSCULOSKELETAL PAIN 270
305 PERICARDIAL EFFUSION 270
306 SUICIDAL IDEATION 270
307 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 266
308 STOMATITIS 265
309 THROMBOSIS 265
310 CAROTID ARTERY THROMBOSIS 264
311 HEAD DISCOMFORT 262
312 EPISTAXIS 258
313 SINUS CONGESTION 258
314 NEUROLOGIC NEGLECT SYNDROME 257
315 HEPATITIS 256
316 ADJUSTMENT DISORDER 253
317 AGITATION 253
318 ULCER 253
319 FEELING HOT 252
320 OEDEMA 252
321 RHINITIS 251
322 SNEEZING 251
323 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 246
324 HYPOXIA 246
325 IMMUNISATION 246
326 URINARY RETENTION 246
327 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 245
328 URINARY INCONTINENCE 243
329 KIDNEY INFECTION 242
330 JAUNDICE 241
331 COLITIS 240
332 HERPES ZOSTER 236
333 IMPAIRED HEALING 236
334 RED BLOOD CELL SEDIMENTATION RATE INCREASED 236
335 CELLULITIS 235
336 NEPHROGENIC ANAEMIA 235
337 SINUS DISORDER 235
338 DIALYSIS 234
339 FREQUENT BOWEL MOVEMENTS 234
340 WHITE BLOOD CELL COUNT INCREASED 234
341 HEPATIC STEATOSIS 233
342 HEART RATE DECREASED 232
343 OCULAR DISCOMFORT 229
344 DELIRIUM 228
345 LETHARGY 228
346 CROHN^S DISEASE 226
347 GAMMA-GLUTAMYLTRANSFERASE INCREASED 226
348 SKIN LESION 226
349 BONE PAIN 222
350 RED BLOOD CELL COUNT DECREASED 222
351 URINARY TRACT DISORDER 220
352 BLOOD ALKALINE PHOSPHATASE INCREASED 219
353 EJECTION FRACTION 218
354 THERAPEUTIC RESPONSE DECREASED 218
355 INTERNATIONAL NORMALISED RATIO INCREASED 217
356 PRODUCT SUBSTITUTION ISSUE 217
357 FLUID RETENTION 216
358 HYPERGLYCAEMIA 215
359 ADVERSE EVENT 213
360 DISORIENTATION 213
361 MATERNAL EXPOSURE DURING PREGNANCY 213
362 ACUTE MYOCARDIAL INFARCTION 211
363 HIATUS HERNIA 211
364 MALNUTRITION 211
365 CHOLELITHIASIS 210
366 EMOTIONAL DISTRESS 210
367 FOETAL EXPOSURE DURING PREGNANCY 210
368 PNEUMONIA ASPIRATION 210
369 AMAUROSIS FUGAX 209
370 POLLAKIURIA 208
371 SKIN HAEMORRHAGE 208
372 MELAENA 206
373 INJECTION SITE REACTION 205
374 ISCHAEMIC STROKE 204
375 GASTRIC DISORDER 203
376 RASH ERYTHEMATOUS 203
377 PULMONARY FIBROSIS 201
378 HAEMATOMA 200
379 ARRHYTHMIA 199
380 DISEASE RECURRENCE 199
381 HYPERTENSIVE NEPHROPATHY 199
382 BLOOD PRESSURE DIASTOLIC DECREASED 198
383 BLOOD CHOLESTEROL INCREASED 197
384 BRONCHIECTASIS 196
385 GANGRENE 196
386 IMPAIRED QUALITY OF LIFE 195
387 COMPLETED SUICIDE 193
388 DIABETIC NEPHROPATHY 193
389 INTESTINAL OBSTRUCTION 191
390 DEPRESSED LEVEL OF CONSCIOUSNESS 190
391 RENAL CYST 190
392 ARTERIAL OCCLUSIVE DISEASE 189
393 ENCEPHALOPATHY 189
394 GINGIVAL PAIN 188
395 OSTEOPENIA 188
396 CARDIAC MURMUR 187
397 TOXIC SKIN ERUPTION 187
398 ACUTE RESPIRATORY FAILURE 186
399 BLOOD UREA INCREASED 186
400 RHEUMATOID NODULE 186
401 INJECTION SITE ERYTHEMA 182
402 ILL-DEFINED DISORDER 180
403 RESPIRATORY DISORDER 179
404 DRUG ABUSE 178
405 TYPE 2 DIABETES MELLITUS 178
406 EYE IRRITATION 177
407 DRUG LEVEL INCREASED 176
408 CORONARY ARTERY DISEASE 175
409 MUCOSAL INFLAMMATION 175
410 BLISTER 174
411 DIVERTICULITIS 174
412 DRUG ERUPTION 174
413 HAEMOPTYSIS 174
414 NEUTROPHIL COUNT DECREASED 172
415 RESPIRATORY TRACT INFECTION 172
416 STAPHYLOCOCCAL INFECTION 172
417 TOXIC EPIDERMAL NECROLYSIS 172
418 HEPATIC FUNCTION ABNORMAL 171
419 PAROSMIA 171
420 PNEUMONITIS 170
421 EPILEPSY 169
422 HYPOPNOEA 167
423 OBSTRUCTIVE AIRWAYS DISORDER 167
424 BLOOD PRESSURE SYSTOLIC ABNORMAL 166
425 CYTOKINE RELEASE SYNDROME 166
426 HEPATIC FAILURE 166
427 ADRENAL INSUFFICIENCY 165
428 SYNOVITIS 165
429 HEAD INJURY 164
430 GASTRIC ULCER 163
431 PULMONARY HYPERTENSION 163
432 CEREBRAL HAEMORRHAGE 159
433 JOINT STIFFNESS 159
434 BURNS SECOND DEGREE 157
435 THERAPY NON-RESPONDER 157
436 NOCTURIA 156
437 BASAL CELL CARCINOMA 155
438 TOOTH DISORDER 155
439 CATARRH 151
440 HYPERCALCAEMIA 150
441 PRODUCT QUALITY ISSUE 150
442 SPEECH DISORDER 150
443 THYROID DISORDER 150
444 BLOOD BILIRUBIN INCREASED 149
445 LIVER FUNCTION TEST ABNORMAL 149
446 PRESCRIBED UNDERDOSE 149
447 NEUTROPHIL COUNT INCREASED 148
448 FULL BLOOD COUNT ABNORMAL 146
449 STEROID DEPENDENCE 146
450 BLOOD PRESSURE DIASTOLIC ABNORMAL 145
451 BONE MARROW FAILURE 144
452 BURSITIS 143
453 FUNGAL INFECTION 143
454 BLOOD CREATINE PHOSPHOKINASE INCREASED 142
455 CYST 142
456 HEPATOTOXICITY 142
457 NEOPLASM MALIGNANT 142
458 LYMPHOCYTE COUNT DECREASED 141
459 BODY TEMPERATURE INCREASED 140
460 COVID-19 PNEUMONIA 140
461 UPPER GASTROINTESTINAL HAEMORRHAGE 140
462 ANAPHYLACTIC SHOCK 139
463 BLOOD POTASSIUM INCREASED 139
464 HEART RATE IRREGULAR 139
465 MULTIPLE SCLEROSIS 139
466 RASH MACULAR 139
467 UNEVALUABLE EVENT 139
468 LIVER INJURY 138
469 RESTLESSNESS 138
470 SKIN DISCOLOURATION 138
471 ACUTE RESPIRATORY DISTRESS SYNDROME 137
472 EPIGASTRIC DISCOMFORT 137
473 IRRITABILITY 137
474 LYMPHADENOPATHY 137
475 ATELECTASIS 136
476 BODY TEMPERATURE DECREASED 136
477 BONE DENSITY DECREASED 136
478 FACE OEDEMA 136
479 FOOT DEFORMITY 136
480 INCORRECT PRODUCT ADMINISTRATION DURATION 136
481 ORTHOSTATIC HYPOTENSION 136
482 PSORIATIC ARTHROPATHY 136
483 GAIT INABILITY 135
484 LIMB DISCOMFORT 135
485 PULMONARY CONGESTION 134
486 VIRAL INFECTION 134
487 VITAMIN D DEFICIENCY 134
488 MUSCULOSKELETAL CHEST PAIN 133
489 RENAL TUBULAR NECROSIS 133
490 SPINAL OSTEOARTHRITIS 133
491 BLOOD POTASSIUM DECREASED 132
492 CONJUNCTIVITIS 132
493 DYSKINESIA 132
494 TREATMENT NONCOMPLIANCE 132
495 UNDERDOSE 132
496 BREATH SOUNDS ABNORMAL 131
497 MOVEMENT DISORDER 131
498 OESOPHAGITIS 131
499 SHOCK 131
500 HYPERLIPIDAEMIA 130
501 BLOOD IRON DECREASED 129
502 SKIN DISORDER 129
503 FEBRILE BONE MARROW APLASIA 128
504 SYNOVIAL CYST 128
505 HALLUCINATION, VISUAL 127
506 TRANSAMINASES INCREASED 127
507 IRON DEFICIENCY ANAEMIA 126
508 OCULAR HYPERAEMIA 126
509 PAIN IN JAW 126
510 MOUTH ULCERATION 125
511 MITRAL VALVE INCOMPETENCE 124
512 UNRESPONSIVE TO STIMULI 124
513 PHOTOSENSITIVITY REACTION 123
514 ERUCTATION 122
515 EYE HAEMORRHAGE 122
516 HAEMATOCRIT DECREASED 122
517 HEPATIC CIRRHOSIS 122
518 NIGHT SWEATS 122
519 FAECES DISCOLOURED 121
520 GASTROENTERITIS 121
521 CHROMATURIA 120
522 GLYCOSYLATED HAEMOGLOBIN INCREASED 120
523 TENDERNESS 120
524 DIABETES MELLITUS INADEQUATE CONTROL 119
525 SHOCK HAEMORRHAGIC 119
526 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 118
527 FEMUR FRACTURE 118
528 HAEMORRHOIDS 118
529 MENTAL DISORDER 118
530 PRODUCT PRESCRIBING ERROR 118
531 BLOOD GLUCOSE DECREASED 117
532 HYPOPHAGIA 117
533 LEUKOCYTOSIS 117
534 STEVENS-JOHNSON SYNDROME 117
535 IMPAIRED GASTRIC EMPTYING 116
536 NEURALGIA 116
537 ORAL HERPES 116
538 ORAL PAIN 116
539 HIP FRACTURE 115
540 MIOSIS 115
541 ACNE 114
542 ELECTROLYTE IMBALANCE 114
543 SINUS TACHYCARDIA 114
544 SUBDURAL HAEMATOMA 114
545 PALLOR 113
546 ACUTE HEPATIC FAILURE 112
547 CLOSTRIDIUM DIFFICILE INFECTION 111
548 LOSS OF EMPLOYMENT 111
549 RIB FRACTURE 111
550 VITAMIN B12 DEFICIENCY 111
551 DEVICE ISSUE 110
552 MOUTH HAEMORRHAGE 110
553 NEPHRECTOMY 110
554 WOUND 110
555 BREAST CANCER 109
556 MUSCULOSKELETAL DISCOMFORT 109
557 SURGERY 109
558 ANHEDONIA 108
559 HYPOPHOSPHATAEMIA 108
560 THERAPY INTERRUPTED 108
561 ALCOHOL POISONING 107
562 BLOOD SODIUM DECREASED 107
563 CHOLECYSTITIS 107
564 LIMB INJURY 107
565 MULTI-ORGAN DISORDER 107
566 CARDIOMEGALY 106
567 DERMATITIS BULLOUS 106
568 ERECTILE DYSFUNCTION 106
569 TOOTH INFECTION 106
570 INJECTION SITE BRUISING 105
571 IRRITABLE BOWEL SYNDROME 105
572 SKIN LACERATION 105
573 SPINAL FRACTURE 105
574 BACTERIAL INFECTION 104
575 DEAFNESS 104
576 MIDDLE INSOMNIA 104
577 REBOUND ACID HYPERSECRETION 104
578 CARDIOGENIC SHOCK 103
579 PYELONEPHRITIS 103
580 CANDIDA INFECTION 102
581 DEAFNESS NEUROSENSORY 102
582 PRODUCT DOSE OMISSION 102
583 DEMENTIA 101
584 DRUG DOSE OMISSION 101
585 INJURY 101
586 TEMPERATURE INTOLERANCE 101
587 ABDOMINAL PAIN LOWER 100
588 GENERALISED TONIC-CLONIC SEIZURE 100
589 INTERVERTEBRAL DISC PROTRUSION 100
590 NERVOUSNESS 100
591 PLATELET COUNT INCREASED 100
592 RESTLESS LEGS SYNDROME 100
593 SUDDEN DEATH 100
594 CEREBRAL INFARCTION 99
595 FACIAL PARALYSIS 99
596 GASTROINTESTINAL MOTILITY DISORDER 99
597 INJECTION SITE PRURITUS 99
598 EXPOSURE DURING PREGNANCY 98
599 HUNGER 98
600 MULTI-ORGAN FAILURE 98
601 SPINAL DISORDER 98
602 AGGRESSION 97
603 PANIC ATTACK 97
604 BLOOD LACTATE DEHYDROGENASE INCREASED 96
605 HAEMOLYTIC ANAEMIA 96
606 NERVE INJURY 96
607 OSTEONECROSIS 96
608 SCIATICA 96
609 TENOSYNOVITIS 96
610 DYSSTASIA 95
611 HYPOALBUMINAEMIA 95
612 PLEURAL FIBROSIS 95
613 POLYURIA 95
614 RESPIRATORY RATE INCREASED 95
615 CLOSTRIDIUM DIFFICILE COLITIS 94
616 CREPITATIONS 94
617 DYSLIPIDAEMIA 94
618 MENTAL STATUS CHANGES 94
619 FEEDING DISORDER 93
620 GASTRIC POLYPS 93
621 LOCALISED INFECTION 93
622 ROAD TRAFFIC ACCIDENT 93
623 EAR INFECTION 92
624 LYMPHOPENIA 92
625 BLOOD PRESSURE SYSTOLIC DECREASED 91
626 HYPERBILIRUBINAEMIA 91
627 POOR QUALITY SLEEP 91
628 PREMATURE BABY 91
629 PRESBYACUSIS 91
630 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 91
631 RALES 91
632 EMPHYSEMA 90
633 NEPHROSCLEROSIS 90
634 NO ADVERSE EVENT 90
635 BLOOD PARATHYROID HORMONE DECREASED 89
636 CHOLECYSTITIS ACUTE 89
637 DRUG DEPENDENCE 89
638 EJECTION FRACTION ABNORMAL 89
639 FOETAL GROWTH RESTRICTION 89
640 HEPATITIS CHOLESTATIC 89
641 JOINT EFFUSION 89
642 JOINT INJURY 89
643 PURPURA 89
644 ANURIA 88
645 DIASTOLIC DYSFUNCTION 88
646 EYELID OEDEMA 88
647 FLANK PAIN 88
648 NEOPLASM PROGRESSION 88
649 SINUS BRADYCARDIA 88
650 ANAEMIA MACROCYTIC 87
651 ATRIOVENTRICULAR BLOCK COMPLETE 87
652 JOINT RANGE OF MOTION DECREASED 87
653 MICTURITION URGENCY 87
654 MYOPATHY 87
655 OBSTRUCTIVE SLEEP APNOEA SYNDROME 87
656 PLASMA CELL MYELOMA 87
657 POST-TRAUMATIC STRESS DISORDER 87
658 PULMONARY MASS 87
659 CHOKING 86
660 ILEUS 86
661 POOR VENOUS ACCESS 86
662 SUPRAVENTRICULAR TACHYCARDIA 86
663 CIRCULATORY COLLAPSE 85
664 COLITIS MICROSCOPIC 85
665 CRYING 85
666 EAR PAIN 85
667 INJECTION SITE EXTRAVASATION 85
668 INJECTION SITE SWELLING 85
669 MYOCARDIAL ISCHAEMIA 85
670 DEFORMITY 84
671 EJECTION FRACTION DECREASED 84
672 FOOT FRACTURE 84
673 HEPATIC ENCEPHALOPATHY 84
674 MONOCYTE COUNT INCREASED 84
675 PNEUMOCYSTIS JIROVECII PNEUMONIA 84
676 SKIN NECROSIS 84
677 TASTE DISORDER 84
678 THROAT TIGHTNESS 84
679 EYE SWELLING 83
680 GLAUCOMA 82
681 HYPOACUSIS 82
682 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 82
683 PHLEBITIS 82
684 POLYP 82
685 FEAR 81
686 GASTRIC CANCER 81
687 ORAL CANDIDIASIS 81
688 PNEUMOTHORAX 81
689 TACHYPNOEA 81
690 TRICUSPID VALVE INCOMPETENCE 81
691 GLOSSODYNIA 80
692 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 80
693 INTERVERTEBRAL DISCITIS 80
694 METASTASES TO LIVER 80
695 RESPIRATORY ARREST 80
696 AZOTAEMIA 79
697 CHRONIC SINUSITIS 79
698 GASTROENTERITIS VIRAL 79
699 POISONING DELIBERATE 79
700 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 79
701 RETCHING 79
702 THERAPEUTIC RESPONSE SHORTENED 79
703 VENTRICULAR HYPOKINESIA 79
704 ACUTE CORONARY SYNDROME 78
705 APHTHOUS ULCER 78
706 CONVULSION 78
707 CYTOMEGALOVIRUS INFECTION 78
708 LARGE INTESTINE POLYP 78
709 ANKLE FRACTURE 77
710 BLOOD COUNT ABNORMAL 77
711 HERNIA 77
712 HYPERTHERMIA 77
713 INJECTION SITE MASS 77
714 LUNG INFECTION 77
715 MYOCARDITIS 77
716 NODULE 77
717 PLEURAL THICKENING 77
718 SEASONAL ALLERGY 77
719 ABNORMAL BEHAVIOUR 76
720 DEMYELINATION 76
721 FEELING JITTERY 76
722 INTENTIONAL DOSE OMISSION 76
723 IRON DEFICIENCY 76
724 PARKINSON^S DISEASE 76
725 INJECTION SITE HAEMORRHAGE 75
726 CHOLANGITIS 74
727 INTENTIONAL SELF-INJURY 74
728 PANNICULITIS 74
729 RHEUMATOID FACTOR POSITIVE 74
730 SPUTUM DISCOLOURED 74
731 URINE OUTPUT DECREASED 74
732 WOUND INFECTION 74
733 ACCIDENTAL EXPOSURE TO PRODUCT 73
734 BLOOD MAGNESIUM INCREASED 73
735 BLOOD URIC ACID INCREASED 73
736 GLOMERULAR FILTRATION RATE DECREASED 73
737 HEPATITIS ACUTE 73
738 SKIN BURNING SENSATION 73
739 TENDON RUPTURE 73
740 VITAMIN D DECREASED 73
741 ANAL ABSCESS 72
742 BACTERAEMIA 72
743 DEVICE RELATED INFECTION 72
744 EXOSTOSIS 72
745 FEELING COLD 72
746 RASH GENERALISED 72
747 BLOOD MAGNESIUM DECREASED 71
748 BLOOD PRESSURE ABNORMAL 71
749 BLOOD TRIGLYCERIDES INCREASED 71
750 BLOOD URINE PRESENT 71
751 CYTOPENIA 71
752 DECREASED IMMUNE RESPONSIVENESS 71
753 DIABETIC KETOACIDOSIS 71
754 ENTEROCOLITIS 71
755 HYDRONEPHROSIS 71
756 PHARYNGEAL SWELLING 71
757 PROCEDURAL PAIN 71
758 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 71
759 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 71
760 ASPIRATION 70
761 COAGULOPATHY 70
762 DERMATITIS EXFOLIATIVE GENERALISED 70
763 FRACTURE 70
764 PLEURITIC PAIN 70
765 PULMONARY TOXICITY 70
766 ATAXIA 69
767 FAECALOMA 69
768 HAEMODIALYSIS 69
769 HALLUCINATION, AUDITORY 69
770 LYMPHOMA 69
771 OROPHARYNGEAL DISCOMFORT 69
772 COLD SWEAT 68
773 HYPERSOMNIA 68
774 HYPERTHYROIDISM 68
775 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 68
776 LEFT VENTRICULAR HYPERTROPHY 68
777 PERITONITIS 68
778 SOPOR 68
779 APHONIA 67
780 DRUG TOLERANCE DECREASED 67
781 GRANULOMA SKIN 67
782 HYPERCHLORHYDRIA 67
783 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 67
784 LUNG NEOPLASM MALIGNANT 67
785 OBESITY 67
786 SPLENOMEGALY 67
787 TORSADE DE POINTES 67
788 TROPONIN INCREASED 67
789 UROSEPSIS 67
790 ECONOMIC PROBLEM 66
791 MASS 66
792 MULTIPLE SCLEROSIS RELAPSE 66
793 ODYNOPHAGIA 66
794 PRODUCT AVAILABILITY ISSUE 66
795 SMALL INTESTINAL OBSTRUCTION 66
796 UPPER-AIRWAY COUGH SYNDROME 66
797 BONE DISORDER 65
798 ELECTRIC SHOCK 65
799 NEPHROTIC SYNDROME 65
800 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 65
801 STATUS EPILEPTICUS 65
802 TENDONITIS 65
803 BLOOD THYROID STIMULATING HORMONE INCREASED 64
804 HAEMODYNAMIC INSTABILITY 64
805 HYPERTENSIVE CRISIS 64
806 MIXED LIVER INJURY 64
807 MOOD ALTERED 64
808 PSEUDOMONAS INFECTION 64
809 SPINAL PAIN 64
810 UTERINE LEIOMYOMA 64
811 ABSCESS 63
812 HUMAN RHINOVIRUS TEST POSITIVE 63
813 LACRIMATION INCREASED 63
814 MOOD SWINGS 63
815 PULMONARY ARTERIAL HYPERTENSION 63
816 TENOSYNOVITIS STENOSANS 63
817 THERAPEUTIC RESPONSE UNEXPECTED 63
818 THERAPY CESSATION 63
819 VENTRICULAR ARRHYTHMIA 63
820 AFFECTIVE DISORDER 62
821 AGEUSIA 62
822 BODY HEIGHT DECREASED 62
823 CARDIOVASCULAR DISORDER 62
824 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 62
825 HELICOBACTER INFECTION 62
826 JOINT DISLOCATION 62
827 LIPASE INCREASED 62
828 NEEDLE ISSUE 62
829 NEPHROPATHY TOXIC 62
830 PNEUMONIA HAEMOPHILUS 62
831 RENAL PAIN 62
832 ROTATOR CUFF SYNDROME 62
833 ANGER 61
834 HYPERCHOLESTEROLAEMIA 61
835 HYPOTHERMIA 61
836 IMMUNODEFICIENCY 61
837 JOINT NOISE 61
838 MUSCLE STRAIN 61
839 PHARYNGITIS 61
840 PRODUCT DOSE OMISSION IN ERROR 61
841 ATRIAL FLUTTER 60
842 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 60
843 CYANOSIS 60
844 ESCHERICHIA INFECTION 60
845 HYPOTONIA 60
846 METASTASES TO BONE 60
847 MUSCLE RIGIDITY 60
848 OSTEONECROSIS OF JAW 60
849 POLYNEUROPATHY 60
850 POST PROCEDURAL COMPLICATION 60
851 SYSTOLIC DYSFUNCTION 60
852 TOOTH FRACTURE 60
853 TOOTHACHE 60
854 VAGINAL HAEMORRHAGE 60
855 ANAL INCONTINENCE 59
856 AORTIC VALVE INCOMPETENCE 59
857 APATHY 59
858 BLOOD PRESSURE DIASTOLIC INCREASED 59
859 BRAIN OEDEMA 59
860 CORONARY ARTERY OCCLUSION 59
861 DRUG EFFECT DECREASED 59
862 MUSCLE HAEMORRHAGE 59
863 PSYCHOTIC DISORDER 59
864 REBOUND EFFECT 59
865 RENAL ATROPHY 59
866 WITHDRAWAL SYNDROME 59
867 EYE INFECTION 58
868 GASTRITIS EROSIVE 58
869 GASTROINTESTINAL INFECTION 58
870 HAND DEFORMITY 58
871 HYPERTRIGLYCERIDAEMIA 58
872 INITIAL INSOMNIA 58
873 INTERVERTEBRAL DISC DEGENERATION 58
874 MYELODYSPLASTIC SYNDROME 58
875 NERVOUS SYSTEM DISORDER 58
876 RENAL CANCER 58
877 SENSORY DISTURBANCE 58
878 SKIN FISSURES 58
879 THIRST 58
880 UPPER LIMB FRACTURE 58
881 ACUTE PULMONARY OEDEMA 57
882 BRADYKINESIA 57
883 CUTANEOUS VASCULITIS 57
884 DIVERTICULUM INTESTINAL 57
885 HYPERNATRAEMIA 57
886 LIVER FUNCTION TEST INCREASED 57
887 RED CELL DISTRIBUTION WIDTH INCREASED 57
888 TONGUE BITING 57
889 TUMOUR LYSIS SYNDROME 57
890 BARRETT^S OESOPHAGUS 56
891 BRONCHOSPASM 56
892 DERMATITIS 56
893 GOUT 56
894 GROIN PAIN 56
895 MUSCLE ATROPHY 56
896 MUSCULOSKELETAL DISORDER 56
897 PELVIC PAIN 56
898 SENSATION OF FOREIGN BODY 56
899 ANTINUCLEAR ANTIBODY POSITIVE 55
900 AREFLEXIA 55
901 ARTERIOSCLEROSIS 55
902 BLOOD CALCIUM DECREASED 55
903 CUSHINGOID 55
904 DERMATITIS CONTACT 55
905 DIVERTICULUM 55
906 ERYTHEMA MULTIFORME 55
907 HYPERPARATHYROIDISM SECONDARY 55
908 INFUSION SITE PAIN 55
909 MYELOSUPPRESSION 55
910 MYOCLONUS 55
911 THERAPY PARTIAL RESPONDER 55
912 THROAT CLEARING 55
913 ANGIOPATHY 54
914 CELL DEATH 54
915 EYE DISORDER 54
916 GASTRIC HAEMORRHAGE 54
917 INCREASED APPETITE 54
918 INJECTION SITE IRRITATION 54
919 LUNG INFILTRATION 54
920 MYOSITIS 54
921 OSTEOSCLEROSIS 54
922 SQUAMOUS CELL CARCINOMA 54
923 BREAST PAIN 53
924 DELUSION 53
925 GLOMERULAR FILTRATION RATE INCREASED 53
926 HAEMORRHAGE INTRACRANIAL 53
927 LIGAMENT SPRAIN 53
928 MENTAL IMPAIRMENT 53
929 MULTIPLE FRACTURES 53
930 PEMPHIGOID 53
931 PHARYNGEAL OEDEMA 53
932 RIGHT VENTRICULAR FAILURE 53
933 SALIVARY HYPERSECRETION 53
934 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 53
935 VENTRICULAR EXTRASYSTOLES 53
936 ABNORMAL LOSS OF WEIGHT 52
937 BLOOD ALBUMIN DECREASED 52
938 BLOOD GLUCOSE ABNORMAL 52
939 CARDIOMYOPATHY 52
940 DISSEMINATED INTRAVASCULAR COAGULATION 52
941 EXTRASYSTOLES 52
942 HYPERURICAEMIA 52
943 PERIPHERAL SENSORY NEUROPATHY 52
944 PRURITUS GENERALISED 52
945 RESPIRATORY ACIDOSIS 52
946 SECRETION DISCHARGE 52
947 TOXIC ENCEPHALOPATHY 52
948 CHRONIC GASTRITIS 51
949 CYTOLYTIC HEPATITIS 51
950 DEVICE DISLOCATION 51
951 DIARRHOEA HAEMORRHAGIC 51
952 FLUID OVERLOAD 51
953 FOLLICULITIS 51
954 OLIGURIA 51
955 POLYARTHRITIS 51
956 VISUAL ACUITY REDUCED 51
957 VITAMIN B12 INCREASED 51
958 ABNORMAL DREAMS 50
959 ASTHMATIC CRISIS 50
960 CEREBRAL HAEMATOMA 50
961 DACTYLITIS 50
962 DEVICE MALFUNCTION 50
963 ENCEPHALITIS 50
964 GRANULOCYTE COUNT INCREASED 50
965 HEPATOMEGALY 50
966 PATHOLOGICAL FRACTURE 50
967 PETECHIAE 50
968 PRODUCT USED FOR UNKNOWN INDICATION 50
969 SCLERITIS 50
970 SKIN PLAQUE 50
971 BACK DISORDER 49
972 DEVICE BREAKAGE 49
973 DUODENITIS 49
974 EOSINOPHIL COUNT INCREASED 49
975 HAEMOLYSIS 49
976 INTESTINAL ISCHAEMIA 49
977 LABORATORY TEST ABNORMAL 49
978 PERIPHERAL COLDNESS 49
979 POST CHOLECYSTECTOMY SYNDROME 49
980 PRODUCT PRESCRIBING ISSUE 49
981 ASPARTATE AMINOTRANSFERASE ABNORMAL 48
982 BACK INJURY 48
983 BLOOD IMMUNOGLOBULIN A INCREASED 48
984 CAROTID ARTERIOSCLEROSIS 48
985 CAROTID ARTERY STENOSIS 48
986 DRUG EFFECT LESS THAN EXPECTED 48
987 DRUG WITHDRAWAL SYNDROME 48
988 DUODENAL ULCER 48
989 DYSPNOEA AT REST 48
990 LEFT VENTRICULAR DYSFUNCTION 48
991 MAST CELL ACTIVATION SYNDROME 48
992 NASAL TURBINATE HYPERTROPHY 48
993 PRESCRIBED OVERDOSE 48
994 RENAL TRANSPLANT 48
995 RHEUMATOID FACTOR INCREASED 48
996 SKIN REACTION 48
997 WHITE BLOOD CELLS URINE POSITIVE 48
998 CORONARY ARTERY STENOSIS 47
999 HEPARIN-INDUCED THROMBOCYTOPENIA 47